Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples